2021
DOI: 10.1016/j.numecd.2020.07.039
|View full text |Cite
|
Sign up to set email alerts
|

Lipid profile and atherogenic indices in patients with stable chronic obstructive pulmonary disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
13
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(15 citation statements)
references
References 40 publications
2
13
0
Order By: Relevance
“… 36 , 37 HDL deficiency resulted in peripheral leukocytosis, including blood eosinophilia, 38 and a 1 mmol/L HDL cholesterol lowering was reported to be correlated with 14.8% higher eosinophils. 34 Given the imbalance in lipid profile in COPD implied by previous studies, 39–41 it is imperative to explore whether the change in HDL level plays a role in eosinophilic COPD, and whether treatment for lower HDL in COPD is beneficial to reduce eosinophil-predominant exacerbation.…”
Section: Discussionmentioning
confidence: 99%
“… 36 , 37 HDL deficiency resulted in peripheral leukocytosis, including blood eosinophilia, 38 and a 1 mmol/L HDL cholesterol lowering was reported to be correlated with 14.8% higher eosinophils. 34 Given the imbalance in lipid profile in COPD implied by previous studies, 39–41 it is imperative to explore whether the change in HDL level plays a role in eosinophilic COPD, and whether treatment for lower HDL in COPD is beneficial to reduce eosinophil-predominant exacerbation.…”
Section: Discussionmentioning
confidence: 99%
“…Although we had adjusted some confounders, whether the association between moderately increased apoB levels and decreased mortality is causal is still an unresolved question to the ndings. Researchers found that, compared to healthy individuals, chronic obstructive pulmonary disease (COPD) patients had higher HDL-C and lower TG, TC, and LDL-C, while those lipid parameters varied reversely in COPD patients with cardiovascular diseases (31). Other disease conditions, including debilitation and wasting in liver diseases, would result in less secretion of lipoproteins (32).…”
Section: Discussionmentioning
confidence: 99%
“…Non-traditional lipid parameters were calculated as follows: non-HDL-C was defined as subtracting serum HDL-C concentration from TC. Atherogenic coefficient was calculated as non-HDL-C/HDL-C; AIP was calculated as log 10 (TG/HDL-C); CRI-I was calculated as TC/HDL-C; and CRI-II was calculated as LDL-C/HDL-C ( 10 , 16 , 17 ).…”
Section: Methodsmentioning
confidence: 99%